Enlivex Ltd. (NASDAQ: ENLV) received Investigational New Drug clearance from the U.S. Food and Drug Administration to proceed with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE